Biotechnology News » develop-and

Arthur Laffer Resigns From Oxigene Board

admin — Tue, 16 Mar 2010 02:57:11 +0000

Oxigene Inc. is a developement stage stage biotechnology company headquartered in South San Francisco, California….

See original here:
Arthur Laffer Resigns From Oxigene Board

Neowater Solubilization Service

admin — Tue, 16 Mar 2010 02:13:24 +0000

Its primal goal is to develop and commercialize novel water-based materials using Nanotechnology for the biotechnology, pharmaceutical and chemical industries….

Read the original:
Neowater Solubilization Service

Australia’s innovation agenda: A stocktake

admin — Tue, 16 Mar 2010 02:04:36 +0000

This is the text of a recent speech given by Dr Terry Cutler, who in 2008 chaired the Australian Gov

See original here:
Australia’s innovation agenda: A stocktake

Regeneration in Mice Through a Single Gene Deletion

admin — Mon, 15 Mar 2010 23:23:42 +0000

Still, learn by doing should be the mantra of modern biotechnology….

Here is the original post:
Regeneration in Mice Through a Single Gene Deletion

3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

admin — Mon, 15 Feb 2010 05:36:25 +0000

3SBio Inc, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis.

Read the original post:
3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)

admin — Mon, 08 Feb 2010 11:46:41 +0000

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

Market Media Connect retained as Northwest Biotherapeutics’ communications agency of record (News-Medical-Net)

admin — Mon, 08 Feb 2010 10:16:37 +0000

Northwest Biotherapeutics, Inc., a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Led from its Los Angeles headquarters, Market Media Connect will support Northwest’s communication objectives as the company moves into the next phase of its …